Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
Anti-Cancer ADC Drugs: 3 Design Elements, 10 Approved ADCs, Multiple Clinical Trials | Biochempeg
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin | Scientific Reports
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
Antibody–Drug Conjugates: Perspectives and Characterization | Chromatography Online
Computationally designed antibody–drug conjugates self-assembled via affinity ligands | Nature Biomedical Engineering
ANTIBODY DRUG CONJUGATES - ADC Development Using SMARTag(TM) Technology
Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
Antibody-drug conjugate - Wikipedia
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
Pharmacokinetic and Immunological Considerations for Expanding the Therapeutic Window of Next-Generation Antibody–Drug Conjugates | SpringerLink
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
ADC Pharmacokinetics Characterization - Creative Biolabs
Bioprocess development of antibody-drug conjugate production for cancer treatment
PDF) Linkers Having a Crucial Role in Antibody–Drug Conjugates
How Far We Have Advanced in the Chemotherapy World - IBL America Online Store
ANTIBODY DRUG CONJUGATES - ADC Development Using SMARTag(TM) Technology
Antibody–drug conjugates | Nature Reviews Drug Discovery
PDF) Analytical methods for physicochemical characterization of antibody drug conjugates
